@timothysnyder.bsky.social
Levin Professor of History at Yale. Author of "On Freedom," "On Tyranny," with 20 new lessons on Ukraine, "Our Malady," "Road to Unfreedom," "Black Earth," and "Bloodlands"
@jamellebouie.net
The real jbouie. Columnist for the New York Times Opinion section. Co-host of the Unclear and Present Danger podcast. b-boy-bouiebaisse on TikTok. jbouienyt on Twitch. National program director of the CHUM Group. Send me your mutual aid requests.
@marcelias.bsky.social
Founder @democracydocket.com. Chair of Elias Law Group. My dog's name is Bode. Visit: democracydocket.com.
@pinksheetsutter.bsky.social
Senior Editor, Citeline's Pink Sheet, covering US FDA drug and biologic regulation and approvals. Views are my own.
@ema.europa.eu
EU regulatory authority working for public and animal health. We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam. https://www.ema.europa.eu/
@bermaninstitute.bsky.social
Our mission: Identify & address key ethical issues in science, clinical care, public health - locally & globally.
@kenwhite.bsky.social
Ken White, criminal defense attorney and First Amendment litigator. Co-host of Serious Trouble podcast and writer at The Popehat Report. Signal: KenWhite.1969
@mcnees.bsky.social
Professor and physicist. Black holes, quantum gravity, cosmology. Rocky Top. Tar Heel. Reposts are spooky action at a distance. These are my views, not my employer's. Just terrible at this.
@doc-jlmeier.bsky.social
Chemical biologist, basketball aficianado, proud homebody. I take my science, not my posts, seriously. Personal account.
@arrakistx.bsky.social
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients.
@ericboodman.bsky.social
Journalist writing narrative features for @statnews.bsky.social and occasional essays elsewhere.
@benthefidler.bsky.social
Biotech journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy. #BioSky
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@ambertongpw.bsky.social
Reporting on China/Asia biotech and pharma for Bloomberg News | 📍 Hong Kong | ptong38@bloomberg.net | Formerly: Endpoints News | Views are my own
@biopharmcatalyst.bsky.social
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks https://www.biopharmcatalyst.com/
@mmolteni.bsky.social
Writing about CRISPR, synthetic bio, reprotech and neuroscience for @statnews. Ex-WIRED. Berkeley journalism alum. Signal: mmolteni.13 ✉️ megan.molteni@statnews.com https://www.statnews.com/
@robertcoffin.bsky.social
Ex-academic (many years ago) & biotech entrepreneur, including at Biovex & $REPL inc
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
@biotech.bsky.social
Biotech Investor | Finance / Biochemistry | Avid Runner | Bay Area / Asia
@science.org
The world's leading outlet for cutting-edge research in all areas of science. https://www.science.org
@natcellbio.nature.com
A journal dedicated to publishing the latest advances across all areas of cell biology. Part of @natureportfolio.nature.com nature.com/ncb/index.html
@statesdj.bsky.social
Chief Science/Medical Officer Angstrom Bio, Austin, TX COI: Our company is developing high throughput diagnostics @statesdj@genomic.social @statesdj@bsky.social
@drannecarpenter.bsky.social
Dedicated to drug discovery, enthralled by science. 5 kids. She. SAB Recursion. Founder SyzOnc. Lab at Broad Institute. Opinions my own.
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@elaineywchen.bsky.social
Reporter @statnews.com covering drugs and the biopharma industry | signal: elaineywchen.70
@raffcolo.bsky.social
ADCs, targeted therapies, chemistry, biotech, pharma. Associate Director @ Zymeworks
@biotechmiller.bsky.social
20+ years in the biotech business. Analyst, portfolio manager, VC, & now doing communications and strategy at Curevo Vaccine. Avid sailor who races. All views are my own. What are you doing with your one wild and precious life? (Mary Oliver)
@jacobplieth.bsky.social
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
@skandaamarnath.bsky.social
Executive Director of Employ America Macro / Labor / Finance / Energy / Chart posting
@annpettifor.bsky.social
I write about the global financial system & its impact on the ecosystem. Books: The Production of Money, The Case for The GND (2018), The Coming First World Debt Crisis (2006). My newsletter: System Change, https://annpettifor.substack.com/
@kevinhorourke.bsky.social
Economist and economic historian. Directeur de Recherche, CNRS and Professor of Economics, Sciences Po, Paris. Website: kevinhorourke.com
@stephaniekelton.bsky.social
Author of the NYT bestseller The Deficit Myth. Professor of Economics and Public Policy at Stony Brook University. Writer of newsletter https://stephaniekelton.substack.com/
@brycecovert.bsky.social
Journalist writing about the economy. Contributing writer at @thenation.com, member of @fspnwu.bsky.social. Send tips to brycecovert@protonmail.com or on Signal: brycecovert.25 she/her
@mims.bsky.social
WSJ tech columnist. Dog person. Author of Arriving Today, an unfortunately timely book about the global system of trade we're currently flushing down the toilet: https://www.harpercollins.com/products/arriving-today-christopher-mims
@jfallows.bsky.social
Reporter and writer: https://fallows.substack.com/ and https://www.ourtownsfoundation.org/ One-time speechwriter, long-time pilot, longer-time husband of linguist/writer Deborah Fallows. Note same wristwatch in the two photos, more than 50 years apart.
@daveweigel.bsky.social
National politics reporter at semafor.com. Alum: WashPost, Bloomberg, Slate, Reason. Author of “The Show That Never Ends.”
@donmoyn.bsky.social
Policy Professor, Ford School, University of Michigan. Irish immigrant. Administrative burdens guy. Free newsletter, Can We Still Govern?: https://donmoynihan.substack.com
@spignal.bsky.social
Charlemagne columnist & Brussels bureau chief, The Economist. Past stints in Paris, Mumbai, London. Français. Personal feed. Bio 👇. https://medium.com/@spignal/stanley-pignal-bio-2acd9b705ceb Charlemagne@economist.com
@george17.bsky.social
China watcher, ex Chief Economist UBS, now at China Centre, Oxford and at SOAS, London. Rock&Indie music lover. Also golden retriever owner and fan.
@econberger.bsky.social
Director of Economic Research at the Burning Glass Institute. I tweet a lot about labor markets, macro, and (sorry) music! Tweets represent my own views.
@tracyalloway.bsky.social
Co-host of the Odd Lots podcast. I like financial crisis hindsight, spurious correlation and puppies. London ➡️New York ➡️Abu Dhabi ➡️Hong Kong ➡️New York
@albertvilella.bsky.social
Bioinformatics Scientist / Next Generation Sequencing, Single Cell and Spatial Biology, Next Generation Proteomics, Liquid Biopsy, SynBio, Compute Acceleration in biotech // http://albertvilella.substack.com
@dieworkwear.bsky.social
Menswear writer. Editor at Put This On. Words at The New York Times, The Washington Post, The Financial Times, Esquire, and Mr. Porter. If you have a style question, search: https://dieworkwear.com/ | https://putthison.com/start-here/
@ptarantinomd.bsky.social
Breast Medical Oncologist, Advanced Fellow Dana-Farber | Harvard | PhD Unimi. SoMe Editor ESMO Open. Interested in breast oncology, HER2, ADCs and good music.